“Fusion and Binding Inhibition” Key Target for HIV-1 Treatment and Pre-Exposure Prophylaxis: Targets, Drug Delivery and Nanotechnology Approaches

Drug Delivery - United Kingdom
doi 10.1080/10717544.2016.1228717
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Antiretroviral-Based HIV-1 Prevention: Antiretroviral Treatment and Pre-Exposure Prophylaxis

Antiviral Therapy
Infectious DiseasesPharmacology
2012English

Bio-Targets and Drug Delivery Approaches

2016English

HIV Pre-Exposure Prophylaxis

CMAJ
Medicine
2014English

Canadian Guideline on HIV Pre-Exposure Prophylaxis and Nonoccupational Postexposure Prophylaxis

CMAJ
Medicine
2018English

Tenofovir-Based Pre-Exposure Prophylaxis for HIV Prevention

Current Opinion in Infectious Diseases
Infectious DiseasesMicrobiology
2012English

Colorectal Delivery and Retention of PEG-Amprenavir-Bac7 Nanoconjugates—proof of Concept for HIV Mucosal Pre-Exposure Prophylaxis

Drug Delivery and Translational Research
Pharmaceutical Science
2015English

HIV Pre-Exposure Prophylaxis (PrEP): Effective but Controversial

Trends in Urology & Men's Health
2017English

Pre-Exposure Prophylaxis for HIV Prevention in Women: Current Perspectives

International Journal of Women's Health
GynecologyOncologyMidwiferyMaternityObstetrics
2017English

Nanotechnology: Advanced Materials and Nanotechnology for Drug Delivery (Adv. Mater. 31/2014)

Advanced Materials
Mechanics of MaterialsMaterials ScienceNanotechnologyMechanical EngineeringNanoscience
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy